Phage Directory Phage Directory

Search

Find articles, people and resources across Phage Directory.

8,013 results

  1. Therapy programs

    Qeen Biotechnologies

    Provider-listed inquiry route. Checked 2026-10-04. Tailored phage development, manufacture, characterization, quality control and regulatory consultation. Institutional P-PEAKS announcement names Qeen as one of three manufacturers. Gatineau

  2. Therapy programs

    UT Health San Antonio phage research collaboration

    Research/development. Checked 2026-10-03. Exploratory phage persistence and production research with UTSA, Texas Biomedical and Brooke Army Medical Center; Phage Refinery commercialization link. San Antonio, Texas; United States research-on

  3. Therapy programs

    Singapore General Hospital

    Intake unconfirmed. Checked 2026-10-03. Personalized IV phages plus antibiotics for difficult implant-associated P. aeruginosa infection; local phage library and manufacture. Singapore; Singapore treating-center SG Hospital-hosted March25,2

  4. Therapy programs

    Stanford Center for Phage Pharmaceuticals

    Research/development. Checked 2026-10-03. 2026 NIAID-supported translational program led by Paul Bollyky; initial focus on developing lung-delivery phages for Pseudomonas infection in CF. Stanford, California; United States research-only US

  5. Therapy programs

    Tabula Bioscience

    Official referral/inquiry route. Checked 2026-10-03. Investigational individualized phage therapies; serious bacterial infections without satisfactory alternatives and infeasible trial participation; isolate matching, manufacturing capacity

  6. Therapy programs

    Texas A&M Center for Phage Technology

    Intake unconfirmed. Checked 2026-10-03. Clinical-support phage sourcing plus bacterial/phage engineering and other preclinical projects. College Station, Texas; United States supplier US CPT supports treating physicians with phage identific

  7. Therapy programs

    Mahidol University / Siriraj phage research

    Research/development. Checked 2026-10-03. Phage diagnostics and therapeutic discovery for AMR organisms, including biofilm/resistance laboratory studies. Bangkok; Thailand research-only TH Official faculty pages describe phage technology an

  8. Therapy programs

    Tolka AI Therapeutics

    Provider-listed inquiry route. Checked 2026-10-05. Personalized phages for NTM lung disease, initially Mycobacterium abscessus complex; serious/life-threatening disease without viable options, trial ineligibility, favorable assessment, supp

  9. Therapy programs

    UC San Diego IPATH

    Case-by-case; Official referral/inquiry route. Checked 2026-10-03. Compassionate-use support for serious resistant or device-associated bacterial infections; prioritizes life/limb-threatening cases, complicated UTIs, transplant and implant-

  10. Therapy programs

    UCSF — former BX004 phage trial site

    Historical/inactive. Checked 2026-10-03. Former phase 2b inhaled BX004 research for adults with CF and chronic Pseudomonas lung infection. San Francisco, California; United States treating-center US Institutional trial page still offers a c

  11. Therapy programs

    UNIFESP Escola Paulista de Medicina — KIDNAP

    Research/development. Checked 2026-10-03. Feasibility/proof-of-concept oral phage trial targeting KPC-producing Klebsiella intestinal colonization in selected high-risk adults; active matching required. São Paulo; Brazil treating-center BR

  12. Therapy programs

    Unity Health Toronto / St. Joseph's — Greg German

    Provider-listed inquiry route. Checked 2026-10-03. Selected difficult chronic bacterial infections; research leadership for P-PEAKS UTI trial and PHAGE4DAIR training. Toronto, Ontario; Canada treating-center CA Clinician referral route is p

  13. Therapy programs

    University of São Paulo CEPID B3 phage research

    Research/development. Checked 2026-10-03. Institutional report of Pseudomonas phage research using in vitro and larvae models, with prospective therapeutic applications. São Paulo; Brazil research-only BR No human therapy intake verified.

  14. Therapy programs

    University of Toronto bacteriophage therapy research initiative

    Research/development. Checked 2026-10-03. Research support across phage biology, clinical translation and proposed Canadian center. Toronto, Ontario; Canada research-only CA Institutional research page and Phage Canada fundraising describe

  16. Therapy programs

    Yale Phage Therapy Program

    Case-by-case; Official referral/inquiry route. Checked 2026-10-03. Clinical phage therapy at Yale and collaborating clinics for antibiotic-resistant bacterial infection; individualized compassionate-use eligibility. New Haven, Connecticut;

  17. Therapy programs

    TASK / Phages4TB consortium

    Research/development. Checked 2026-10-03. Mycobacteriophage discovery, ex-vivo sputum work and clinical trial preparation for pulmonary tuberculosis; planned adjunctive antibiotics. Cape Town; South Africa company ZA Official EU project rep

  18. Therapy studies

    STAMP

    Recruiting. Checked 2026-10-03. Standardized monitoring of personalized phage treatment; adults and children in an Australian multisite network. ACTRN12621001526864